Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy

Michele L. Pearson; Joseph V. Selby; Kenneth A. Katz; Virginia Cantrell; Christopher R. Braden; Monica E. Parise; Christopher D. Paddock; Michael R. Lewin-Smith; Victor F. Kalasinsky; Felicia C. Goldstein; Allen W. Hightower; Arthur Papier; Brian Lewis; Sarita Motipara; Mark L. Eberhard; for the Unexplained Dermopathy Study Team

doi:10.1371/journal.pone.0029908

Loading metrics

Open Access

Peer-reviewed

Research Article

Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy

Michele L. Pearson,

Affiliation Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
⨯
Joseph V. Selby,

Affiliation Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America
⨯
Kenneth A. Katz,

Affiliation HIV, STD, and Hepatitis Branch, Health and Human Services Agency, County of San Diego, San Diego, California, United States of America
⨯
Virginia Cantrell,

Affiliation Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America
⨯
Christopher R. Braden,

Affiliation Division of Food, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
⨯
Monica E. Parise,

Affiliation Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
⨯
Christopher D. Paddock,

Affiliation Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
⨯
Michael R. Lewin-Smith,

Affiliation Environmental Pathology, Joint Pathology Center, Silver Spring, Maryland, United States of America
⨯
Victor F. Kalasinsky,

Affiliation Office of Research & Development, United States Department of Veterans Affairs, Washington, District of Columbia, United States of America
⨯
Felicia C. Goldstein,

Affiliation Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, United States of America
⨯
Allen W. Hightower,

Affiliation Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
⨯
Arthur Papier,

Affiliation Department of Dermatology, University of Rochester School of Medicine, Rochester, New York, United States of America
⨯
Brian Lewis,

Affiliation Division of Health Studies, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, United States of America
⨯
Sarita Motipara,

Affiliation Division of Research, Kaiser Permanente Northern California, Oakland, California, United States of America
⨯
Mark L. Eberhard ,

* E-mail: mle1@cdc.gov

Affiliation Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
⨯
[ ... ],
for the Unexplained Dermopathy Study Team

¶Additional membership of the Unexplained Dermopathy Study Team is provided in the Acknowledgments.
⨯
[ view all ]
[ view less ]

Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy

Michele L. Pearson,
Joseph V. Selby,
Kenneth A. Katz,
Virginia Cantrell,
Christopher R. Braden,
Monica E. Parise,
Christopher D. Paddock,
Michael R. Lewin-Smith,
Victor F. Kalasinsky,
Felicia C. Goldstein

Published: January 25, 2012
https://doi.org/10.1371/journal.pone.0029908

Reader Comments

Post a new comment on this article

Question on Disclaimer

Posted by Ruthintoronto on 27 Apr 2012 at 20:56 GMT

I would like to know if this normal procedure to to have a Disclaimer attached to a study that was requested by the CDC. Have the CDC done this in previous studies? Thank You. Ruth

"DISCLAIMER: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, Kaiser Permanente or the Armed Forces Institute of Pathology."

No competing interests declared.

RE: Question on Disclaimer

MattJHodgkinson replied to Ruthintoronto on 03 Jul 2012 at 14:05 GMT

Yes, this a standard CDC disclaimer

Competing interests declared: I am an Associate Editor for PLoS ONE

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Biopsy
Is the Subject Area "Biopsy" applicable to this article?

Thanks for your feedback.
Fibers
Is the Subject Area "Fibers" applicable to this article?

Thanks for your feedback.
Surveys
Is the Subject Area "Surveys" applicable to this article?

Thanks for your feedback.
California
Is the Subject Area "California" applicable to this article?

Thanks for your feedback.
Cellulose
Is the Subject Area "Cellulose" applicable to this article?

Thanks for your feedback.
Neuropsychological testing
Is the Subject Area "Neuropsychological testing" applicable to this article?

Thanks for your feedback.
Parasitic diseases
Is the Subject Area "Parasitic diseases" applicable to this article?

Thanks for your feedback.

Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy

Clinical, Epidemiologic, Histopathologic and Molecular Features of an Unexplained Dermopathy

Reader Comments

Post Your Discussion Comment

Why should this posting be reviewed?

Thank You!

Question on Disclaimer

Posted by Ruthintoronto on 27 Apr 2012 at 20:56 GMT

RE: Question on Disclaimer

MattJHodgkinson replied to Ruthintoronto on 03 Jul 2012 at 14:05 GMT